Apixaban Discontinuation Prior To Major Surgery: Results From A Prospective Single Center Study
In: Department of Pharmacology and Experimental Therapeutics Posters, 2019
Bild
Zugriff:
Primary Objective Estimate the proportion of patients who achieve a plasma apixaban concentration of/mL following at least 48 hours of discontinuation prior to surgery or invasive procedure Secondary Objective Perioperative and follow up arterial or venous thromboembolic events, major bleeding, clinically significant non-major bleeding complications. Correlation of apixaban anti-Factor Xa (FXa) activity and plasma apixaban concentrations at pre-admission and prior to surgery ; https://jdc.jefferson.edu/petposters/1006/thumbnail.jpg
Titel: |
Apixaban Discontinuation Prior To Major Surgery: Results From A Prospective Single Center Study
|
---|---|
Autor/in / Beteiligte Person: | Lam, Edwin ; Eraso, Luis ; Galanis, Taki ; Kraft, Walter K. ; Ouma, Geoffrey ; Thomson, Lynda ; Viscusi, Eugene ; Stickle, Douglas ; Gong, Jerald Z ; Adams, Suzanne ; Merli, Geno |
Link: | |
Zeitschrift: | Department of Pharmacology and Experimental Therapeutics Posters, 2019 |
Veröffentlichung: | Jefferson Digital Commons, 2019 |
Medientyp: | Bild |
Schlagwort: |
|
Sonstiges: |
|